F/M Investments’s KalVista Pharmaceuticals KALV Stock Holding History

F/M Investments’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-226,991	Closed	-$4.57M	–	372
2026 Q1	$4.57M	Sell	226,991 -9,699	-4%	-$156K	0.3%	71
2025 Q4	$3.82M	Buy	236,690 +37,486	+19%	+$496K	0.15%	172
2025 Q3	$2.43M	Buy	199,204 +16,942	+9%	+$234K	0.09%	216
2025 Q2	$2.06M	Buy	182,262 +132,165	+264%	+$1.62M	0.07%	238
2025 Q1	$578K	Buy	+50,097	New	+$511K	0.02%	320

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

F/M Investments's KALV Position: Q2 2026 in Review

F/M Investments sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 226,991 shares — an estimated $4.57M sold.

F/M Investments first reported a position in KALV in Q1 2025 and held it in 5 quarters. The position peaked at $4.57M in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

F/M Investments reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
F/M Investments sold 226,991 KalVista Pharmaceuticals shares in Q2 2026, an estimated $4.57M.
F/M Investments first reported a position in KalVista Pharmaceuticals in Q1 2025 and held it in 5 quarters.
F/M Investments's KalVista Pharmaceuticals position peaked at $4.57M in Q1 2026.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.